Arm Holdings shares fell more than 6% on Tuesday after HSBC downgraded the chip designer to Hold, saying foundry capacity constraints are likely to limit earnings upside despite the company's strong long-term growth prospects. The brokerage still raised its price target to $315 from $255.
HSBC has downgraded AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) to 'hold' from 'buy', arguing that a recent trial failure has removed the central pillar of its bull case and left a tougher path ahead. The bank cut its target price to 13,750p from 16,500p, implying limited upside.
HSBC is tightening private credit exposure by limiting higher-risk fund financing, sharpening its focus on disciplined lending and risk-adjusted returns.
| Banks Industry | Financials Sector | Georges Bahjat Elhedery CEO | XMEX Exchange | 404280406 CUSIP |
| GB Country | 211,940 Employees | 15 May 2026 Last Dividend | 7 Jul 1999 Last Split | - IPO Date |
HSBC Holdings plc stands as a global provider of banking and financial solutions, offering its diverse services across the world. The company, which laid its foundations in 1865, is headquartered in London, the United Kingdom. It operates through three main segments: Wealth and Personal Banking, Commercial Banking, and Global Banking and Markets, each designed to cater to different customer needs ranging from personal banking customers and high net worth individuals to small and middle enterprises, as well as corporates, government entities, and institutional clients.
HSBC Holdings plc's comprehensive portfolio of products and services is strategically segmented to address the unique requirements of its varied client base across the globe. These offerings include: